Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 6Completed 4No longer available 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 1Ganglioneuroma 1Ganglioneuroblastoma 1

Interventions

pembrolizumab 225Cyclophosphamide 194Radiotherapy 181Nivolumab 181Carboplatin 155Paclitaxel 114Cisplatin 113Dexamethasone 111Radiosurgery 103Magnetic Resonance Spectroscopy 98Surveys and Questionnaires 92Ipilimumab 82Doxorubicin 80Lenalidomide 77durvalumab 76Rituximab 75atezolizumab 73Radiation 72venetoclax 69Standard of Care 69fludarabine 68Gemcitabine 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Docetaxel 60Oxaliplatin 59Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Ga(III)-DOTATOC × Clear all
NCT04040088 2026-03-31

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Mayo Clinic

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
CNS

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡